10-48450277-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021226.4(ARHGAP22):c.1852G>A(p.Glu618Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000069 in 1,609,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021226.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGAP22 | NM_021226.4 | c.1852G>A | p.Glu618Lys | missense_variant | 9/10 | ENST00000249601.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGAP22 | ENST00000249601.9 | c.1852G>A | p.Glu618Lys | missense_variant | 9/10 | 1 | NM_021226.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000525 AC: 8AN: 152252Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000253 AC: 6AN: 237294Hom.: 0 AF XY: 0.0000231 AC XY: 3AN XY: 129842
GnomAD4 exome AF: 0.0000707 AC: 103AN: 1457460Hom.: 0 Cov.: 37 AF XY: 0.0000649 AC XY: 47AN XY: 724738
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152252Hom.: 0 Cov.: 34 AF XY: 0.0000403 AC XY: 3AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 01, 2023 | The c.1852G>A (p.E618K) alteration is located in exon 9 (coding exon 9) of the ARHGAP22 gene. This alteration results from a G to A substitution at nucleotide position 1852, causing the glutamic acid (E) at amino acid position 618 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at